LMP2A (426-434) is a HLA-A2 restricted cytoxic T lymphocyte (CTL) epitope of Epstein-Barr virus (EBV) latent membrane protein 2A (LMP2A). LMP2A (426-434) can trigger an immune response in individuals expressing different HLA-A*02 subtypes. LMP2A can induce a strong IFN-gamma secretion response, stimulating the production of a high proportion of CD8 IFN-gamma T cells. LMP2A induces specific CTLs to effectively kill target cells expressisng LMP2A (426-434) can be used to study EBV-related malignant tumores (such as Hodfkin's disease and nasopharyngeal carcinoma).
Usually ships within 24 hours.